Correlation Engine 2.0
Clear Search sequence regions


  • after treatment (1)
  • antigens (2)
  • antigens cd (2)
  • burns (1)
  • CCL1 (11)
  • ccl1 protein, human (1)
  • CD14 (4)
  • CD163 (4)
  • cells (8)
  • child (1)
  • chimera (3)
  • gene (1)
  • growth (1)
  • host (1)
  • human (4)
  • human cells (1)
  • lethal dose (1)
  • macrophages (2)
  • male (1)
  • methicillin (2)
  • mice (3)
  • monocytes (1)
  • nucleic acid (1)
  • ODNs (1)
  • oligonucleotides (2)
  • patients (6)
  • protein human (1)
  • receptors (4)
  • rna (2)
  • sepsis (1)
  • staphylococcus aureus (2)
  • Sizes of these terms reflect their relevance to your search.

    M2b macrophages (Mφ) play a major role in the increased susceptibility of subacutely burned patients, to sepsis stemming from enterococcal translocation. Certain opportunistic infections in severely burned mice have been controlled by murine CCL1 antisense oligodeoxynucleotide (ODN), a specific polarizer of mouse M2bMφ. In the present study, we have screened CCL1 antisense ODN, which is active against human M2bMφ. Among the 20 CCL1 antisense ODNs synthesized in our laboratory, HCA-11 was shown to be the most active polarizer for human CCL1+CD163+CD14+ cells. Burn patient CCL1+CD163+CD14+ cells (3 × 105 cells/mL) switched to quiescent CCL1-CD163-CD14+ cells within 48 h in cultures supplemented with 100 μg/mL of HCA-11. After treatment with a 25 μg/chimera dose of HCA-11, the bacterial growth was not observed in various organs of patient chimeras (γNSG mice inoculated with burn patient WBCs) infected with a lethal dose of Methicillin-resistant Staphylococcus aureus. The host antibacterial defenses against certain opportunistic pathogens should be improved in severely burned patients treated with a human CCL1 antisense ODN, HCA-11.

    Citation

    Ichiaki Ito, Kamlesh K Bhopale, Tomoki Nishiguchi, Jong O Lee, David N Herndon, Sumihiro Suzuki, Lawrence C Sowers, Fujio Suzuki, Makiko Kobayashi. The Polarization of M2b Monocytes in Cultures of Burn Patient Peripheral CD14+ Cells Treated with a Selected Human CCL1 Antisense Oligodeoxynucleotide. Nucleic acid therapeutics. 2016 Oct;26(5):269-276

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 27548631

    View Full Text